{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:13:49Z","timestamp":1792192429892,"version":"4.4.0"},"reference-count":25,"publisher":"American Society of Hematology","issue":"19","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,5,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>There are unresolved questions regarding the association between persistent leukocytosis and risk of thrombosis and disease evolution in polycythemia vera (PV), as much of the published literature on the topic does not appropriately use repeated-measures data or time-dependent modeling to answer these questions. To address this knowledge gap, we analyzed a retrospective database of 520 PV patients seen at 10 academic institutions across the United States. Taking hematologic laboratory data at \u223c3-month intervals (or as available) for all patients for duration of follow-up, we used group-based trajectory modeling to identify latent clusters of patients who follow distinct trajectories with regard to their leukocyte, hematocrit, and platelet counts over time. We then tested the association between trajectory membership and hazard of 2 major outcomes: thrombosis and disease evolution to myelofibrosis, myelodysplastic syndrome, or acute myeloid leukemia. Controlling for relevant covariates, we found that persistently elevated leukocyte trajectories were not associated with the hazard of a thrombotic event (P = .4163), but were significantly associated with increased hazard of disease evolution in an ascending stepwise manner (overall P = .0002). In addition, we found that neither hematocrit nor platelet count was significantly associated with the hazard of thrombosis or disease evolution.<\/jats:p>","DOI":"10.1182\/blood.2019003347","type":"journal-article","created":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T23:19:47Z","timestamp":1582845587000},"page":"1696-1703","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":85,"title":["Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis"],"prefix":"10.1182","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2310-5345","authenticated-orcid":false,"given":"Lukas","family":"Ronner","sequence":"first","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3657-778X","authenticated-orcid":false,"given":"Nikolai","family":"Podoltsev","sequence":"first","affiliation":[{"name":"Hematology Section, Department of Medicine, Yale School of Medicine, New Haven, CT;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Gotlib","sequence":"first","affiliation":[{"name":"Stanford Cancer Institute, Stanford, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark L.","family":"Heaney","sequence":"first","affiliation":[{"name":"Columbia University Medical Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"Kuykendall","sequence":"first","affiliation":[{"name":"H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey","family":"O\u2019Connell","sequence":"first","affiliation":[{"name":"Keck School of Medicine, University of Southern California, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamile","family":"Shammo","sequence":"first","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, Rush University Medical Center, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela G.","family":"Fleischman","sequence":"first","affiliation":[{"name":"Division of Hematology and Oncology, Chao Family Comprehensive Cancer Center, UCI Health, Irvine, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn M.","family":"Scherber","sequence":"first","affiliation":[{"name":"Division of Hematology and Oncology, Mays Cancer Center, UT Health San Antonio MD Anderson, San Antonio, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Mesa","sequence":"first","affiliation":[{"name":"Division of Hematology and Oncology, Mays Cancer Center, UT Health San Antonio MD Anderson, San Antonio, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5293-4620","authenticated-orcid":false,"given":"Abdulraheem","family":"Yacoub","sequence":"first","affiliation":[{"name":"University of Kansas Cancer Center, Westwood, KS;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecelia","family":"Perkins","sequence":"first","affiliation":[{"name":"Stanford Cancer Institute, Stanford, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelby","family":"Meckstroth","sequence":"first","affiliation":[{"name":"Yale School of Public Health, New Haven, CT;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Behlman","sequence":"first","affiliation":[{"name":"Hematology Section, Department of Medicine, Yale School of Medicine, New Haven, CT;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Chiaramonte","sequence":"first","affiliation":[{"name":"Columbia University Medical Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahta","family":"Salehi","sequence":"first","affiliation":[{"name":"Keck School of Medicine, University of Southern California, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimia","family":"Ziadkhanpour","sequence":"first","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hellen","family":"Nguyen","sequence":"first","affiliation":[{"name":"Division of Hematology and Oncology, Chao Family Comprehensive Cancer Center, UCI Health, Irvine, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Siwoski","sequence":"first","affiliation":[{"name":"University of Kansas Cancer Center, Westwood, KS;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie Kwok","family":"Hung","sequence":"first","affiliation":[{"name":"Division of Hematology and Oncology, Mays Cancer Center, UT Health San Antonio MD Anderson, San Antonio, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Janania Martinez","sequence":"first","affiliation":[{"name":"Division of Hematology and Oncology, Mays Cancer Center, UT Health San Antonio MD Anderson, San Antonio, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Nguyen","sequence":"first","affiliation":[{"name":"Division of Hematology and Oncology, Chao Family Comprehensive Cancer Center, UCI Health, Irvine, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar","family":"Patel","sequence":"first","affiliation":[{"name":"Keck School of Medicine, University of Southern California, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Revathi","family":"Kollipara","sequence":"first","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, Rush University Medical Center, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami","family":"Dave","sequence":"first","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, Rush University Medical Center, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Randall","sequence":"first","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, Rush University Medical Center, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1709-7633","authenticated-orcid":false,"given":"Michael","family":"Grant","sequence":"first","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, Rush University Medical Center, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Harrison","sequence":"first","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, Rush University Medical Center, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Fernandez Soto","sequence":"first","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, Rush University Medical Center, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4719-7192","authenticated-orcid":false,"given":"Douglas","family":"Tremblay","sequence":"first","affiliation":[{"name":"Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Hoffman","sequence":"first","affiliation":[{"name":"Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8912-4709","authenticated-orcid":false,"given":"Erin","family":"Moshier","sequence":"first","affiliation":[{"name":"Department of Population Health Science and Policy, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8400-0483","authenticated-orcid":false,"given":"John","family":"Mascarenhas","sequence":"first","affiliation":[{"name":"Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"20","key":"2020050711241126500_B1","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"13","key":"2020050711241126500_B2","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1182\/blood-2001-12-0349","article-title":"Polycythemia vera: myths, mechanisms, and management","volume":"100","author":"Spivak","year":"2002","journal-title":"Blood"},{"issue":"9","key":"2020050711241126500_B3","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1038\/leu.2013.163","article-title":"Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study","volume":"27","author":"Tefferi","year":"2013","journal-title":"Leukemia"},{"issue":"11","key":"2020050711241126500_B4","doi-asserted-by":"crossref","first-page":"e366","DOI":"10.1038\/bcj.2015.95","article-title":"Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors","volume":"5","author":"Cerquozzi","year":"2015","journal-title":"Blood Cancer J"},{"issue":"6","key":"2020050711241126500_B5","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3324\/haematol.2014.106013","article-title":"Optimal therapy for polycythemia vera and essential thrombocythemia can only be determined by the completion of randomized clinical trials","volume":"99","author":"Mascarenhas","year":"2014","journal-title":"Haematologica"},{"issue":"23","key":"2020050711241126500_B6","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1182\/blood-2013-01-478891","article-title":"Revised response criteria for polycythemia vera and essential thrombocythemia: an ELN and IWG-MRT consensus project","volume":"121","author":"Barosi","year":"2013","journal-title":"Blood"},{"issue":"5","key":"2020050711241126500_B7","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1056\/NEJMoa1409002","article-title":"Ruxolitinib versus standard therapy for the treatment of polycythemia vera","volume":"372","author":"Vannucchi","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"2020050711241126500_B8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1208500","article-title":"Cardiovascular events and intensity of treatment in polycythemia vera","volume":"368","author":"Marchioli","year":"2013","journal-title":"N Engl J Med"},{"issue":"16","key":"2020050711241126500_B9","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1056\/NEJMc1301262","article-title":"Treatment target in polycythemia vera","volume":"368","author":"McMullin","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"2020050711241126500_B10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/bjh.14798","article-title":"Cytogenetic findings in WHO-defined polycythaemia vera and their prognostic relevance","volume":"182","author":"Barraco","year":"2018","journal-title":"Br J Haematol"},{"issue":"2","key":"2020050711241126500_B11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/bjh.12117","article-title":"Leucocytosis and thrombosis at diagnosis are associated with poor survival in polycythaemia vera: a population-based study of 327 patients","volume":"160","author":"Bonicelli","year":"2013","journal-title":"Br J Haematol"},{"issue":"3","key":"2020050711241126500_B12","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2141.2007.06674.x","article-title":"Leucocytosis in polycythaemia vera predicts both inferior survival and leukaemic transformation","volume":"138","author":"Gangat","year":"2007","journal-title":"Br J Haematol"},{"issue":"6","key":"2020050711241126500_B13","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1182\/blood-2006-08-042515","article-title":"Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera","volume":"109","author":"Landolfi","year":"2007","journal-title":"Blood"},{"issue":"5","key":"2020050711241126500_B14","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1365-2141.2009.07804.x","article-title":"Postpolycythaemic myelofibrosis: frequency and risk factors for this complication in 116 patients","volume":"146","author":"Alvarez-Larr\u00e1n","year":"2009","journal-title":"Br J Haematol"},{"issue":"1","key":"2020050711241126500_B15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","article-title":"Group-based trajectory modeling in clinical research","volume":"6","author":"Nagin","year":"2010","journal-title":"Annu Rev Clin Psychol"},{"issue":"2","key":"2020050711241126500_B16","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap): a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"3","key":"2020050711241126500_B17","first-page":"122","article-title":"The Effect of Glucose Levels Prior to Hematopoietic Cell Transplantation on Post-Transplant Complications and Health Resource Utilization","volume":"13","author":"Steinberg","year":"2019","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"issue":"3","key":"2020050711241126500_B18","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/0049124101029003005","article-title":"A SAS Procedure Based on Mixture Models for Estimating Developmental Trajectories","volume":"29","author":"Jones","year":"2001","journal-title":"Sociol Methods Res"},{"issue":"2","key":"2020050711241126500_B19","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/S2352-3026(16)30184-3","article-title":"Statins and primary prevention of venous thromboembolism: a systematic review and meta-analysis","volume":"4","author":"Kunutsor","year":"2017","journal-title":"Lancet Haematol"},{"issue":"10","key":"2020050711241126500_B20","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.numecd.2019.06.022","article-title":"Statins and risk of thromboembolism: A meta-regression to disentangle the efficacy-to-effectiveness gap using observational and trial evidence","volume":"29","author":"Miksza","year":"2019","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"16","key":"2020050711241126500_B21","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"issue":"11","key":"2020050711241126500_B22","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1182\/bloodadvances.2019000211","article-title":"Leukocytosis and thrombosis in essential thrombocythemia and polycythemia vera: a systematic review and meta-analysis","volume":"3","author":"Carobbio","year":"2019","journal-title":"Blood Adv"},{"issue":"4","key":"2020050711241126500_B23","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1182\/blood-2015-04-638593","article-title":"White blood cell counts and thrombosis in polycythemia vera: a subanalysis of the CYTO-PV study","volume":"126","author":"Barbui","year":"2015","journal-title":"Blood"},{"issue":"6","key":"2020050711241126500_B24","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1182\/blood-2006-09-046342","article-title":"Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status","volume":"109","author":"Carobbio","year":"2007","journal-title":"Blood"},{"issue":"6","key":"2020050711241126500_B25","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/ejh.12759","article-title":"Influence of platelet and white blood cell counts on major thrombosis - analysis from a patient registry in essential thrombocythemia","volume":"97","author":"Buxhofer-Ausch","year":"2016","journal-title":"Eur J Haematol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/135\/19\/1696\/1726878\/bloodbld2019003347.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/135\/19\/1696\/1726878\/bloodbld2019003347.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T15:24:32Z","timestamp":1588865072000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/135\/19\/1696\/452581\/Persistent-leukocytosis-in-polycythemia-vera-is"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,7]]},"references-count":25,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2020,5,7]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2019003347","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,7]]}}}